These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10854555)

  • 41. Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study.
    Thuss-Patience PC; Kretzschmar A; Repp M; Kingreen D; Hennesser D; Micheel S; Pink D; Scholz C; Dörken B; Reichardt P
    J Clin Oncol; 2005 Jan; 23(3):494-501. PubMed ID: 15659494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
    Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
    Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer.
    Gómez-Martín C; Salazar R; Montagut C; Gil-Martín M; Núñez JA; Puig M; Lin X; Khosravan R; Tursi JM; Lechuga MJ; Bellmunt J
    Invest New Drugs; 2013 Apr; 31(2):390-8. PubMed ID: 22615059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical evaluation as palliative therapy of combination chemotherapy with continuous infusional 5-fluorouracil and consecutive low-dose cisplatin in unresectable gastrointestinal carcinoma].
    Yasumoto K; Takeda J; Iwamoto M; Kawabata S; Takeuchi K; Yunoki T Miwa K; Iwakuma N; Shirouzu K
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1909-14. PubMed ID: 9797813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The French experience with infusional 5-FU in gastric and pancreatic cancer.
    Ducreux M; Rougier P
    J Infus Chemother; 1996; 6(4):203-5. PubMed ID: 9229316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II evaluation of low-dose continuous 5-fluorouracil and weekly cisplatin in advanced adenocarcinoma of the stomach. A Southwest Oncology Group study.
    Williamson SK; Tangen CM; Maddox AM; Spiridonidis CH; Macdonald JS
    Am J Clin Oncol; 1995 Dec; 18(6):484-7. PubMed ID: 8526189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neoadjuvant chemotherapy in high-grade advanced gastric cancer with protracted infusional 5-fluorouracil and consecutive low-dose cisplatin].
    Kondo K; Murase M; Yokoyama Y; Kato J; Hibi K; Kasai Y; Akiyama S; Ito K; Takagi H
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1299-303. PubMed ID: 8831742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Docetaxel-cisplatin-5-FU combination chemotherapy as a first-line treatment in patients with metastatic or recurred gastric cancer].
    Kang SH; Kim JI; Goh PG; Hwang SW; Kwon DS; Nam KW; Kang HM; Kang YS; Moon HS; Kim SH; Seong JK; Lee BS; Jeong HY
    Korean J Gastroenterol; 2007 Sep; 50(3):157-63; discussion 207-9. PubMed ID: 17885280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
    Hartmann JT; Pintoffl JP; Al-Batran SE; Quietzsch D; Meisinger I; Horger M; Nehls O; Bokemeyer C; Königsrainer A; Jäger E; Kanz L
    Onkologie; 2007 May; 30(5):235-40. PubMed ID: 17460417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisplatin plus continuous infusion of 5-fluorouracil for 5 days effective for patients with advanced gastric cancer.
    Okada Y; Anai H; Hattori T; Maehara Y; Nishimura J; Sugimachi K; Nawata H
    Anticancer Drugs; 1991 Oct; 2(5):453-6. PubMed ID: 1804387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Two patients with far advanced gastric cancer responding to combination chemotherapy with 5-FU and CDDP].
    Mochizuki F; Tomioka K; Mizuno Y; Sato F; Yamagata T; Nagakawa Y; Kobari Y; Fujii M; Iwai S; Tanaka T
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):115-8. PubMed ID: 7826065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.
    Hwang J; Cho SH; Shim HJ; Lee SR; Ahn JS; Yang DH; Kim YK; Lee JJ; Kim HJ; Chung IJ
    J Korean Med Sci; 2008 Aug; 23(4):586-91. PubMed ID: 18756042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients.
    Sakaeda T; Yamamori M; Kuwahara A; Hiroe S; Nakamura T; Okumura K; Okuno T; Miki I; Chayahara N; Okamura N; Tamura T
    Ther Drug Monit; 2008 Aug; 30(4):497-503. PubMed ID: 18641541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase II study of combination therapy with 5'-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci.
    Koizumi W; Kurihara M; Sasai T; Yoshida S; Morise K; Imamura A; Akazawa S; Betsuyaku T; Ohkubo S; Takahashi H
    Cancer; 1993 Aug; 72(3):658-62. PubMed ID: 8334621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
    Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM
    Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
    Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.
    Melcher AA; Mort D; Maughan TS
    Br J Cancer; 1996 Nov; 74(10):1651-4. PubMed ID: 8932350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The clinical effect of low-dose FP (5-FU + low-dose CDDP) in patients with far advanced gastric cancer, and their quality of life].
    Murakami S; Yoshida K; Kin R; Nishimoto N; Kagawa Y; Yano Y; Nishiyama M; Hirai T; Toge T
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):853-8. PubMed ID: 10897211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
    Ahn JH; Kang YK; Kim TW; Bahng H; Chang HM; Kang WC; Kim WK; Lee JS; Park JS
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):104-10. PubMed ID: 12172973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.